CYANOTECH CORP

CYAN · OTCM

CIK 768408fmd_1WFYECN65J7CMJNWJ34S9GAVC9Manufacturing · Medicinal Chemicals & Botanical ProductsTemplate: Standard

Coverage: Apr 01, 2009 to Sep 30, 2025, 63 periods

Income Statement · Annual · Millions · USD
Line item	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Total revenues	32	32	34	30	32	32	36	23	23	24
Cost of revenue	20	20	21	20	19	21	22	16	17	17
Gross profit	12	12	13	10	13	11	14	7	6	7
Research and development	1	1	1	1	1	1	1	1	1	0
Selling, general and administrative	12	12	11	13	11	10	10	9	10	9
Total operating expenses	13	13	12	13	12	11	11	10	11	9
Operating income	(1)	(1)	1	(3)	1	0	3	(3)	(5)	(3)
Interest expense	–	–	0	1	1	1	0	1	1	1
Other non-operating income (expense)	(0)	(1)	(0)	(1)	(1)	1	(0)	(1)	–	–
Income before taxes	(1)	(1)	1	(4)	0	1	2	(3)	(5)	(3)
Income tax expense	3	0	(0)	0	0	0	0	0	0	0
Net income from continuing operations	(4)	(1)	1	(4)	0	1	2	(3)	(5)	(3)
Net income	(4)	(1)	1	(4)	0	1	2	(3)	(5)	(3)
Net income to common shareholders	–	–	–	–	–	–	–	–	–	–